News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Sanofi-Aventis (France)'s Zentiva CEO Michal To Step Down
June 30, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Dow Jones -- Sanofi-Aventis SA said Tuesday that Jiri Michal, the chief executive of Zentiva NV, the Czech-based generics unit of the French-Swiss pharmaceutical company, is stepping down as of July 1 after 36 years at the company.
Twitter
LinkedIn
Facebook
Email
Print
People
Sanofi
MORE ON THIS TOPIC
Deals
An Insmed takeout by Sanofi would be ‘clear strategic fit’ in respiratory space
November 20, 2026
·
2 min read
·
Heather McKenzie
Cancer
Merck-Kelun ADC scores survival win in Phase 3 gastroesophageal cancer trial
November 20, 2026
·
3 min read
·
Gabrielle Masson
Earnings
Novartis projects slowed growth, pins hopes on billions in pipeline potential
November 19, 2026
·
3 min read
·
Annalee Armstrong
Alzheimer’s disease
Actinogen’s sole drug fails pivotal Alzheimer’s study, sinking stock 80%
November 19, 2026
·
1 min read
·
Gabrielle Masson